Drugs becoming eligible for first Paragraph IV ANDA filing in 2031
Drugs expiring in 2032
Azacitidine patents expiration
Drugs that contains Ambrisentan
Fosamax Plus D patents expiration
Drugs that contains Patisiran Sodium
Zepatier patents expiration
Covis patents expiration
